For: | Li XF, Jiang Z, Gao Y, Li CX, Shen BZ. Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients. World J Gastroenterol 2016; 22(38): 8576-8583 [PMID: 27784970 DOI: 10.3748/wjg.v22.i38.8576] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i38/8576.htm |
Number | Citing Articles |
1 |
Răzvan Ciocan, Andra Ciocan, Florin Mihăileanu, Cristina-Paula Ursu, Ștefan Ursu, Cătălin Bodea, Ariana-Anamaria Cordoș, Bogdan Chiș, Nadim Al Hajjar, Noemi Dîrzu, Dan-Sebastian Dîrzu. Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers—A Systematic Review. International Journal of Molecular Sciences 2024; 25(4): 2381 doi: 10.3390/ijms25042381
|
2 |
Delphine Dayde, Ichidai Tanaka, Rekha Jain, Mei Tai, Ayumu Taguchi. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. International Journal of Molecular Sciences 2017; 18(3): 573 doi: 10.3390/ijms18030573
|
3 |
Mladen Marinkovic, Suzana Stojanovic-Rundic, Aleksandra Stanojevic, Marija Ostojic, Dusica Gavrilovic, Radmila Jankovic, Natasa Maksimovic, Rafael Stroggilos, Jerome Zoidakis, Sergi Castellví-Bel, Remond J. A. Fijneman, Milena Cavic. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1245594
|
4 |
N. G. Vasilchenko, D. S. Kutilin, N. N. Timoshkina, D. S. Potyomkin, S. I. Poluektov, M. A. Gusareva, N. G. Kosheleva, K. I. Soldatova, A. Y. Maksimov, O. I. Kit, Yu. S. Sidorenko. MODERN RADIOTHERAPY REGIMENS AND BIOMARKERS OF RADIORESISTANT RECTAL TUMOR CELLS. Siberian journal of oncology 2020; 18(6): 105 doi: 10.21294/1814-4861-2019-18-6-105-113
|
5 |
Lili Qin, Yueqi Wang, Na Yang, Yangyu Zhang, Tianye Zhao, Yanhua Wu, Jing Jiang. Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis. PeerJ 2021; 9: e10859 doi: 10.7717/peerj.10859
|
6 |
He Zhou, Tao Huang, Yongfu Xiong, Linglong Peng, Rong Wang, Guang jun Zhang. The prognostic value of proliferating cell nuclear antigen expression in colorectal cancer. Medicine 2018; 97(50): e13752 doi: 10.1097/MD.0000000000013752
|
7 |
Iris H. Wei, Julio Garcia-Aguilar. Non-operative management of rectal cancer: understanding tumor biology. Minerva Chirurgica 2018; 73(6) doi: 10.23736/S0026-4733.18.07743-X
|
8 |
Toshinori Kobayashi, Mitsuaki Ishida, Hisanori Miki, Yuki Matsumi, Toshiro Fukui, Madoka Hamada, Koji Tsuta, Mitsugu Sekimoto. p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study. Colorectal Disease 2021; 23(5): 1083 doi: 10.1111/codi.15486
|
9 |
Daniëlle Krijgsman, Jessica Roelands, Morten N. Andersen, Cornelia H.L.A. Wieringa, Rob A.E.M. Tollenaar, Wouter Hendrickx, Davide Bedognetti, Marianne Hokland, Peter J.K. Kuppen. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. Molecular Immunology 2020; 128: 205 doi: 10.1016/j.molimm.2020.10.012
|